ANG Lifesciences India
Close ·
- P/E
- Not meaningful: loss-making over the last twelve months
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures at the close · EPS basis: Consolidated · TTM
- ROCE
- −2.32%
- Debt to Equity
- 1.49
- EPS (TTM)
- −₹10.21
- Book Value
- ₹36.91
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 1.01
- ROE
- −16.50%
- Dividend Yield
- 2.78%
- EBITDA
- ₹1.30 Cr
- 52W High
- ₹49.69
- 52W Low
- ₹17.63
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 88/100
Category scores
- Quality
- 58
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 88
- Strong
- Cheap vs sector & own history 24% weight
- Growth
- 18
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 16
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 92
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.93 times its book value
Weaknesses
5- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -9.66% over past five years.
- Company has a low return on equity of -14.4% over last 3 years.
- Promoters have pledged 44.9% of their holding.
- Company has high debtors of 267 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 3 | 4 | 12 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Overall
Strong Bullish
Moving Averages
Strong Bullish
Key readings
- RSI (14)
- 56.63
- Neutral
- MACD (12,26,9)
- −0.43
- Bullish
- SMA (50)
- 35.31
- Bullish
- SMA (200)
- 29.89
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 5Y | −9.60% |
|---|---|
| 3Y | −24.95% |
| 1Y | 0.00% |
| TTM | −15.60% |
Net profit
| 5Y | Turned to loss |
|---|---|
| 3Y | Turned to loss |
| 1Y | Loss narrowed by ₹1 Cr |
| TTM | Loss widened by ₹1.97 Cr |
Operating cash flow
| 5Y | — |
|---|---|
| 3Y | −24.93% |
| 1Y | Zero base |
| TTM | — |
5Y: The statements do not go back far enough for this window.
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 5Y | −5.86 pp |
|---|---|
| 3Y | −3.59 pp |
| 1Y | +4.31 pp |
| TTM | −2.32 pp |
Revenue by year
| Mar 2021 | ₹154 Cr |
|---|---|
| Mar 2022 | ₹354 Cr |
| Mar 2023 | ₹220 Cr |
| Mar 2024 | ₹145 Cr |
| Mar 2025 | ₹93.00 Cr |
| Mar 2026 | ₹93.00 Cr |
Net profit by year
| Mar 2021 | ₹7.00 Cr |
|---|---|
| Mar 2022 | ₹40.00 Cr |
| Mar 2023 | ₹0.00 Cr |
| Mar 2024 | −₹10.00 Cr |
| Mar 2025 | −₹12.00 Cr |
| Mar 2026 | −₹11.00 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 56.46 | 33.26 | 18.55 | 37.84 | 18.41 | 32.88 | 24.73 | 16.82 | 24.6 | 26.05 | 18.73 | 23.5 | 15.3 |
| Expenses | 49.92 | 31.6 | 20.46 | 34.48 | 20.12 | 30.6 | 26.88 | 17.52 | 23.95 | 25.97 | 21.41 | 20.82 | 17.25 |
| Operating Profit | 6.54 | 1.66 | −1.91 | 3.36 | −1.71 | 2.28 | −2.15 | −0.7 | 0.65 | 0.08 | −2.68 | 2.68 | −1.95 |
| OPM % | 11.58% | 4.99% | −10.3% | 8.88% | −9.29% | 6.93% | −8.69% | −4.16% | 2.64% | 0.31% | −14.31% | 11.4% | −12.75% |
| Other Income | 0.32 | 0.22 | −0.03 | −1.55 | 1.28 | 0.35 | −0.27 | 0.65 | 0.09 | 0.12 | 0.16 | 0.17 | 0.11 |
| Interest | 2.31 | 2.29 | 2.51 | 3.84 | 2.08 | 2.18 | 2 | 2.42 | 1.94 | 1.89 | 1.93 | 2.18 | 2.24 |
| Depreciation | 2.19 | 2.22 | 1.91 | 2.05 | 1.63 | 1.74 | 1.96 | 1.42 | 1.53 | 1.52 | 1.51 | 1.77 | 1.5 |
| PBT | 2.36 | −2.63 | −6.36 | −4.08 | −4.14 | −1.29 | −6.38 | −3.89 | −2.73 | −3.21 | −5.96 | −1.1 | −5.58 |
| Tax % | 25.85% | −12.17% | −6.92% | −10.54% | −25.85% | 62.02% | −18.65% | −47.04% | −26.74% | −8.41% | −20.3% | 25.45% | −24.01% |
| Net Profit | 1.75 | −2.32 | −5.93 | −3.65 | −3.07 | −2.09 | −5.19 | −2.06 | −2.01 | −2.95 | −4.75 | −1.38 | −4.24 |
| EPS (₹) | 1.34 | −1.78 | −4.54 | −2.8 | −2.35 | −1.6 | −3.97 | −1.58 | −1.54 | −2.26 | −3.64 | −1.06 | −3.25 |
Profit & Loss
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 154 | 354 | 220 | 145 | 93 | 93 | 84 |
| Expenses | 140 | 286 | 205 | 135 | 94 | 90 | 85 |
| Operating Profit | 14 | 68 | 15 | 10 | −1 | 3 | −2 |
| OPM % | 9% | 19% | 7% | 7% | −1.6% | 2.8% | −2.2% |
| Other Income | 1 | 1 | 10 | −1 | 2 | −1 | 1 |
| Interest | 4 | 9 | 12 | 11 | 9 | 8 | 8 |
| Depreciation | 1 | 6 | 9 | 8 | 7 | 6 | 6 |
| PBT | 10 | 54 | 3 | −11 | −16 | −13 | −16 |
| Tax % | 31% | 25% | 110% | −5% | −21% | −15% | — |
| Net Profit | 7 | 40 | 0 | −10 | −12 | −11 | −13 |
| EPS (₹) | 5.26 | 31.02 | −0.2 | −7.77 | −9.5 | −8.49 | −10.21 |
| Div. Payout % | 0% | 3% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity Capital | — | 10 | 13 | 13 | 13 | 13 |
| Reserves | — | 73 | 73 | 63 | 51 | 40 |
| Borrowings | — | 77 | 71 | 73 | 83 | 79 |
| Other Liabilities | — | 130 | 119 | 92 | 82 | 78 |
| Total Liabilities | — | 290 | 276 | 241 | 230 | 210 |
| Fixed Assets | — | 93 | 88 | 58 | 57 | 51 |
| CWIP | — | 0 | 0 | 0 | 0 | 0 |
| Investments | — | 0 | 0 | 0 | 0 | 0 |
| Other Assets | — | 198 | 188 | 183 | 172 | 160 |
| Total Assets | — | 290 | 276 | 241 | 230 | 210 |
Cash Flow
₹ Cr| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Operating | — | 25 | 26 | −9 | 0 | 11 |
| Investing | — | −44 | −9 | 20 | −2 | 1 |
| Financing | — | 20 | −17 | −10 | 2 | −12 |
| Net Cash Flow | — | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | — | −17 | 16 | 9 | −4 | 11 |
| CFO/OP | — | 37 | 202 | 39 | −272 | 429 |
Ratios
| Particulars | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor Days | — | 105 | 138 | 184 | 262 | 267 |
| Inventory Days | — | 59 | 118 | 183 | 331 | 288 |
| Days Payable | — | 113 | 165 | 254 | 405 | 317 |
| Cash Conversion Cycle | — | 51 | 91 | 113 | 189 | 238 |
| Working Capital Days | — | 20 | 24 | 58 | 72 | −8 |
| ROCE % | — | — | 9% | 1% | −4% | −2% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view ANG Lifesciences insights
63 extracted metrics across FY13–FY27.
Documents
- 30 May 2026
- 24 Aug 2026
- 29 Sep 2025
- 21 Aug 2024
- 21 Feb 2024
- 30 Nov 2023
- General announcements 16 Oct 2026
Frequently Asked Questions about ANG Lifesciences India
What does ANG Lifesciences India Ltd do?
Where is ANG Lifesciences India Ltd (ANG) listed?
Which sector does ANG Lifesciences India Ltd belong to?
What is the 52-week high and low of ANG Lifesciences India Ltd?
Does ANG Lifesciences India Ltd pay dividends?
What is the Return on Equity (ROE) of ANG Lifesciences India Ltd?
Company Information
Incorporated in 2006, ANG Lifesciences India Ltd is in the business of pharmaceuticals products & formulations, and packaging and printing.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/540694.md for ANG Lifesciences India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.